Ascendis Pharma
ASND
ASND
23 hedge funds and large institutions have $184M invested in Ascendis Pharma in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-3
Holders Change %
-11.54%
% of All Funds
0.61%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
7
Increased
10
Reduced
3
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
O
OrbiMed
New York
|
$29.1M |
2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
$45.3M |
3 |
VC
Vivo Capital
Palo Alto,
California
|
$23.4M |
4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
$3.47M |
5 |
BBA
Baker Bros. Advisors
New York
|
$9.89M |